HQY Financials

Income Statement
MetricQ2 2027Q1 2027Q4 2026Q3 2026Q2 2026
Revenue
350.7M
-1.1%
354.6M
+6.0%
334.6M
+3.9%
322.2M
-1.1%
325.8M
Cost of Revenue
92.8M
-5.6%
98.3M
-7.6%
106.4M
+13.1%
94.1M
+0.9%
93.2M
Gross Profit
258.0M
+0.6%
256.3M
+12.3%
228.1M
+0.0%
228.1M
-1.9%
232.6M
Operating Expenses
159.3M
+3.9%
153.4M
-2.4%
157.1M
+5.2%
149.4M
+4.5%
143.0M
R&D
73.9M
+9.1%
67.8M
-3.7%
70.4M
+6.7%
65.9M
+1.7%
64.8M
SG&A
58.1M
+0.2%
58.0M
-0.8%
58.5M
+5.7%
55.3M
+10.8%
49.9M
Operating Income
98.7M
-4.1%
103.0M
+44.9%
71.1M
-9.7%
78.7M
-12.2%
89.6M
EBITDA
141.6M
-0.5%
142.3M
+28.1%
111.1M
-6.4%
118.6M
-8.3%
129.3M
Net Income
65.6M
-5.4%
69.4M
+39.6%
49.7M
-3.8%
51.7M
-13.6%
59.9M
EPS (Basic)
$0.79
-3.7%
$0.82
+41.4%
$0.58
-3.3%
$0.60
-13.0%
$0.69
EPS (Diluted)
$0.78
-4.9%
$0.82
+43.9%
$0.57
-3.4%
$0.59
-13.2%
$0.68
Shares (Diluted)
84.0M
-1.2%
85.0M
-2.0%
86.8M
-0.2%
87.0M
-0.9%
87.7M
HealthEquity (HQY) โ€” Financials